Left Menu
Development News Edition

Delhi-based Dr Dangs selected as central lab for Covaxin human clinical trials

"We are extremely privileged to announce that Dr. Dangs Lab, New Delhi has been provided the opportunity to serve the nation by being selected as the central lab for the Human Clinical trials of Covaxin; India's indigenous COVID-19 vaccine being developed and manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV)," it said in a statement. This is a "randomised, double blind, placebo controlled multi-centric clinical trial in India", it added.

PTI | New Delhi | Updated: 23-07-2020 14:46 IST | Created: 23-07-2020 14:46 IST
Delhi-based Dr Dangs selected as central lab for Covaxin human clinical trials

A Delhi-based private laboratory has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology.

Dr. Dangs Lab said on Wednesday that it has partnered with Bharat Biotech for conducting the trials. "We are extremely privileged to announce that Dr. Dangs Lab, New Delhi has been provided the opportunity to serve the nation by being selected as the central lab for the Human Clinical trials of Covaxin; India's indigenous COVID-19 vaccine being developed and manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV)," it said in a statement.

This is a "randomised, double blind, placebo controlled multi-centric clinical trial in India", it added. "Dr. Dangs Lab is currently processing all samples for screening and safety for the various phases of this clinical trial, whereas all the efficacy studies will be performed in NIV (Pune)," the statement said.

The lab has already started receiving samples from 50 to 100 subjects per day from various trial sites for safety testing and will be increasing operations as per assigned timelines to cover 12 sites across the length and breadth of the country over this month, it added. "Stringent quality norms driven by good clinical laboratory practice (GCLP) guidelines are being followed as mandated by regulatory authorities. The lab has renowned experts in each field who are working tirelessly and collectively to provide quality and timely results to fulfil the imminent need of an effective and safe COVID19 vaccine," the statement said.


TRENDING

OPINION / BLOG / INTERVIEW

How UK’s 'best prepared' healthcare system failed to gauge COVID-19

The UK is proud of their public health system and its unlike any other country as around 90 percent of British public supports the founding principles of National Health Service. But without accurate data being available to stakeholders in ...

Poor on IHR capacity progress in 2019, WHO says Cambodia tops COVID-19 response

Despite being in proximity to Hubei, the original epicenter of COVID-19 pandemic, Cambodia has reported just 226 confirmed cases and zero deaths. After seeing the data, WHO appreciated Cambodias healthcare information system but experts dou...

Loopholes in Healthcare Information System may have failed Singapore COVID-19 model

In the initial days of the COVID-19 outbreak, Singapore was in the limelight for its effective healthcare system and pandemic response plan. However, Singapore has now joined the list of the worst-hit nations and the situation is even worse...

Australia's COVID-19 response: Digital infrastructure of help but implementation remains a challenge

Australias ongoing plans to upgrade its health information system helped by the Digital Health Strategy seem even more practical due to the pandemic. But as evident during the pandemic, administrative lapses and the complex matrix of power ...

Videos

Latest News

Tennis-WTA Tour returns with Palermo Open to mark new normal amid pandemic

Nearly five months after the sport was suspended due to the coronavirus pandemic, Donna Vekic became the first player to win a main draw match in the COVID-19 era, beating Arantxa Rus 6-1 6-2 in the first round of the Palermo Ladies Open on...

California governor says COVID-19 cases, hospitalizations, trending down

The governor of California said on Monday that rates of new COVID-19 cases, hospitalizations and intensive care unit admissions were all trending down in the state, according to the latest analysis.Governor Gavin Newsom, a Democrat, said in...

Thai protesters openly criticise monarchy

Speakers at a Thai anti-government protest demanded reforms to the monarchy of King Maha Vajiralongkorn on Monday, calling for its powers to be curbed in unusually frank public comments. Defaming the monarchy is punishable by up to 15 years...

US STOCKS-Nasdaq ends at record high as traders eye M&A and stimulus

The Nasdaq closed at a record high on Monday as a rebound in multibillion-dollar deals, including Microsofts pursuit of TikToks U.S. operations, lifted sentiment, and efforts to hammer out a coronavirus relief bill resumed.Microsoft jumped ...

Give Feedback